Ann: Quarterly Report and Appendix 4C, page-110

The prospectus states that they're waiting for the approvals and laws to come through before they commit to this stuff, which was my point. The company isn't going broke wasting tens of millions of medical marijuana, it's just waiting and focusing on aspects of the business that can make money. Their focus is on the hemp side of the business and that is where their current investment spending is going into, as they've clearly laid out.

When things do loosen up on medical marijuana then I'd love to see those investments move forward. Medical marijuana is still very much up in the air, it's still early days all around the world. We don't know how it'll settle down, or how it'll work exactly in Australia. But getting a profitable business up and running on the side and waiting to see how things play out is a good approach. Let other companies blow their investor's money on research, maybe we can partner up and grow for the winner.